#coronavirus #postcovid #medical technology

American Scientists Are Developing a Universal COVID-19 Vaccine

28 de octubre de 2025

2 min de lectura

The developers of this experimental vaccine report that it has the potential to protect from all COVID-19 strains. It is estimated that the vaccine could cost less than $1 USD per dose.

Puntos clave

The developers of this experimental vaccine report that it has the potential to protect from all COVID-19 strains.
Targeting the spike protein
Different vaccine approaches

Para quién es

Personas que exploran Ornament Blog a través de coronavirus, postcovid.

Por qué importa

Este artículo te ayuda a orientarte rápidamente y luego avanzar a una colección o serie si quieres seguir profundizando.

Autor del artículo

Dra. Asya

Asesora científica

Científico jefe de Ornament Health AG Endocrinólogo Doctor en Ciencias Médicas Graduado de la Escuela de Estudios Avanzados SISSA, Trieste, Italia, con una especialización en enfermedades neurodegenerativas Anteriormente: Becario de investigación, Universidad de Oslo Mejor científico joven de Italia, 2006 Ganador de la beca internacional Human Frontier ## Experiencia Elina dirige el equipo internacional de científicos médicos de Ornament Health AG y es responsable de la información médica y científica y de la prevención de enfermedades. Elina también dirige el consejo asesor científico internacional y aporta su experiencia científica profesional en las áreas de desarrollo más prometedoras de la empresa. Anteriormente, Elina Sharifullina trabajó para la empresa biofarmacéutica internacional Swedish Orphan Biovitrum (SOBI), gestionando el marketing en Rusia y los países de la CEI. También trabajó con la empresa internacional MSD (EE.UU.) en medicamentos para el tratamiento de la diabetes mellitus y fue asesora médica de la oficina de Moscú de Eli Lilly (EE.UU.) en el campo de la endocrinología. Elina se graduó en la Universidad Médica Estatal de Kazán con una especialización en endocrinología y, en 2006, se doctoró en enfermedades neurodegenerativas en la Escuela Internacional de Investigación Avanzada SISSA (Trieste, Italia). De 2007 a 2010, Elina fue becaria de investigación en la Universidad de Oslo (Noruega). Elina ha dedicado la mayor parte de su vida a la ciencia y la medicina, investigando en los campos de la diabetes mellitus, la obesidad, las enfermedades del sistema nervioso central y el biohacking. Fue galardonada con el título de mejor científica joven de Italia en 2006 y es la ganadora de la beca internacional Human Frontier.

Experto en salud

Targeting the spike protein

The vaccine is aimed at the part of the COVID spike (S) protein that is resistant to mutations and is common for almost all types of coronaviruses.

During the experiment, the vaccine was used to vaccinate pigs infected by two types of coronaviruses — COVID-19 and porcine epidemic diarrhea virus (PEDV). These two coronaviruses are related, but they are distant relatives. The researchers have assumed that if the vaccine against COVID-19 can also protect a pig from PEDV, it will also be capable of protecting a wide range of various coronavirus strains.

The vaccine has not prevented infection but has prevented a severe form of the disease. It has also made the pigs' immune system develop a stronger response to future infection.

For the moment, the researchers will have to find an optimal dose, the best route of administering the vaccine, and an optimal dosage schedule. They also plan to experiment with other substances that can be added to further increase the immune response.

Different vaccine approaches

Modern vaccines work by tricking human cells into producing incomplete versions of the COVID spike (S) protein. The immune system reacts to it by building a defense against future attacks. The Pfizer and Moderna (mRNA) vaccines do this by entering genetic information directly into the cells through the messenger RNA. The Johnson & Johnson vaccine uses modified adenovirus for harmless infection of the cells. Both of these types of vaccines get into the cells and make them develop vaccine antigens.

The experimental vaccine uses another approach. The researchers genetically engineered E. coli (Escherichia coli) bacteria, destroying those of their components that cause disorders and adding a coronavirus target protein. After that, the bacteria are killed and introduced into the human body, where the immune system identifies them as an aggressor and develops a response.

In this case, the immune response is caused by bacteria instead of what is produced by body cells. The bacteria-based vaccines are referred to as inactivated (dead) whole-cell vaccines. They have been known for a hundred years and need only a cold chain for transportation. This requirement makes their mass application much simpler than, for example, mRNA vaccines requiring a deep freeze.

Cheaper means better

The mRNA vaccines used today against COVID-19 cost around $10 per dose, which can be too expensive for developing countries. However, bacteria-based vaccines can be produced on a large scale at very low prices. In the past, a South Korean company produced 6 million doses of cholera vaccine in one year at less than $1 per dose. If the developers of the universal coronavirus vaccines succeed, the price would be approximately the same.

Source: https://medicalxpress.com/news/2021-04-cheap-universal-coronavirus-vaccine.htm

Seguir leyendo

Ornament Blog#ornament blog

How Genetically Modified Mosquitoes Will Protect People From Dangerous Diseases

Aedes aegypti mosquitoes live in a tropical climate and carry dangerous diseases such as dengue fever and the Zika virus. Annually, $1 million USD is budgeted to combat malevolent mosquitoes. The new development by the biotech company Oxitec, which has created genetically modified mosquitoes, will cost less and be more effective. This is an important development because mosquitoes become pesticide-resistant over time.

Alina28 oct 2025

Ornament Blog#estilo de vida saludable

First-Ever ‘Living’ Robots Created by American Scientists

American scientists from the University of Vermont have used the Deep Green supercomputer to create a new life-form — living robots. The unique xenobots were built using living cells from frog embryos.

Dra. Asya28 oct 2025

Estilo de vida saludable#glaucoma

The Beginners’ Guide: What You Need To Know About Cannabidiol (CBD)

So you have heard about CBD and it can help you with your problem, but you don’t know where to start. Here is a short beginner’s guide to CBD!

Dra. Asya28 oct 2025

Coronavirus#coronavirus

What Vitamins Help With Recovery From COVID-19?

Any viral infection, whether it is ARVI or temperature, changes the human immune system. People who have had COVID-19 claim that after the disease they began to notice a constant loss of strength, decreased performance, lethargy, deterioration of mood, headaches, shortness of breath during exercise, and exacerbation of chronic diseases. What vitamins should be taken to "invigorate" the immune system after COVID-19?

Dra. Diana28 oct 2025

Instala Ornament para no solo leer estos artículos, sino también hacer seguimiento de tu salud, guardar resultados de análisis y acceder a otras funciones útiles

Instalar Ornament